| Titre : | Continued signs of resilience in the European drug market: Highlights from the EMCDDA's 2016 European drug report (2016) |
| Auteurs : | J. MOUNTENEY ; P. GRIFFITHS ; A. CUNNINGHAM ; M. EVANS-BROWN ; M. FERRI ; D. HEDRICH ; A. NOOR |
| Type de document : | Article : Périodique |
| Dans : | Drugs: Education, Prevention and Policy (Vol.23, n°6, December 2016) |
| Article en page(s) : | 492-495 |
| Langues: | Anglais |
| Discipline : | EPI (Epidémiologie / Epidemiology) |
| Mots-clés : |
Organismes OEDTThésaurus géographique EUROPEThésaurus mots-clés MDMA-ECSTASY ; MARCHE DE LA DROGUE ; INTERNET ; CANNABIS ; DROGUES DE SYNTHESE ; MORTALITE |
| Résumé : | May 2016 saw the launch of the European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDA) annual review of the European drug situation, incorporating situational and trend analysis, statistical data and individual country information (EMCDDA, 2016a). As in previous years (Mounteney & Griffiths, 2014; Mounteney, Zobel, & Griffiths, 2013), we present highlights from the report which can be accessed in its entirety at: www.emcdda.europa.eu. Overall, the 2016 analysis highlights a resilient European drug market, with recent survey data showing modest increases in the estimated prevalence of use of cannabis and stimulant drugs and the purity or potency levels of most illicit substances either high or increasing. [Extract] |
| Domaine : | Drogues illicites / Illicit drugs |
| Affiliation : | EMCDDA, Lisbon, Portugal |
| Cote : | Abonnement |
| - voir aussi : |
Accueil
